| ²é¿´: 924 | »Ø¸´: 2 | ||||||||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßsmzhlcf½«ÔùËÍÄú 200 ¸ö½ð±Ò | ||||||||
smzhlcfÒø³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇóÖú»ù½ðժҪһƪ£ºÏø´Ä£ÐÍ´óÊóÆøµÀÃÔ×ßÖÐÊàÈ¥ÒÖÖÆµÄ»úÖÆ¼°°ûÍâºËÜÕËá´úлºÍµ÷½ÚÒì³£
|
|||||||
ÇóÖú»ù½ðժҪһƪ£ºÏø´Ä£ÐÍ´óÊóÆøµÀÃÔ×ßÖÐÊàÈ¥ÒÖÖÆµÄ»úÖÆ¼°°ûÍâºËÜÕËá´úлºÍµ÷½ÚÒì³£ÔÚÆäÖеÄ×÷Óã¡ |
» ²ÂÄãϲ»¶
297£¬¹¤¿Æµ÷¼Á?
ÒѾÓÐ4È˻ظ´
¿ÒÇëÓÐѧУÊÕÁô
ÒѾÓÐ7È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
300Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
22ר˶Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
²ÄÁÏÏà¹Ø×¨Òµ344Çóµ÷¼ÁË«·Ç¹¤¿ÆÑ§Ð£»ò¿ÎÌâ×é
ÒѾÓÐ25È˻ظ´
¼±Ðèµ÷¼Á
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
sweeticeman
гæ (ÖøÃûдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 470
- É¢½ð: 800
- ºì»¨: 4
- ɳ·¢: 5
- Ìû×Ó: 1659
- ÔÚÏß: 49.7Сʱ
- ³æºÅ: 3368692
- ×¢²á: 2014-08-16
- ÐÔ±ð: GG
- רҵ: »úе½á¹¹Ç¿¶Èѧ
2Â¥2018-08-19 08:35:29
wangjijiang
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1556.7
- É¢½ð: 500
- Ìû×Ó: 75
- ÔÚÏß: 244.8Сʱ
- ³æºÅ: 412463
- ×¢²á: 2007-06-25
- רҵ: ºôÎüϵͳ¼²²¡ÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Ïø´ÊÇÂýÐÔÆøµÀÑ×ÐÔ¼²²¡,°é½ôÕźͷ´ÉäÐÔÆøµÀÃÔ×ßÉñ¾»î¶¯ÔöÇ¿¡£ÑÏÖØ·¢×÷ʱ,ÆøµÀÃÔ×ßÉñ¾»î¶¯³ÊÓëÑ×Ö¢³Ì¶ÈÎ޹صijÖÐø½ôÕÅ,µ«ÖÐÊà»úÖÆ²»Ã÷;ÎüÈëÌÇÆ¤Öʼ¤ËؽáºÏ¦Â2ÉöÉÏÏÙËØÊÜÌ弤¶¯¼ÁÁÆÐ§ºÜ²î,µ«¿¹µ¨¼îÒ©ÄÜÓÐЧ¿ØÖÆ¡£ÔÚÏø´´óÊóÆøµÀÃÔ×ßÖÐÊà,ÎÒÃÇǰÆÚ·¢ÏÖС½ºÖÊϸ°û(MG)±»¼¤»î,ÔÚ±¾ÏîÄ¿½øÒ»²½¼ÙÉèÕâÖÖMG¼¤»îÒÔM2ÐÍΪÖ÷,ÇÒÆä·ÖÃÚµÄBDNFͨ¹ý¼¤»îÉñ¾ÔªÉϵÄTrkBÊÜÌå,Éϵ÷1ÐÍNa+-K+-2Cl-ͬÏòתÔËÌå,ϵ÷2ÐÍK+-Cl-ͬÏòתÔËÌå,ʹÉñ¾Ôª¶ÔÒÖÖÆÐÔÉñ¾µÝÖʵķ´Ó¦¼õÈõÉõÖÁ·´×ªÎªÐË·Ü,·¢ÉúÈ¥ÒÖÖÆ¡£ATPÊÇÖØÒªµÄMG¼¤»îÎïÖÊ¡£ÎÒÃǼÙÉèÏø´Ê±MG¼¤»îÓÉÍâºËÜÕËáøCD39ºÍCD73±í´ïϵ÷¡¢àÑßÊÄÜP2X4ÐÍÊÜÌåÉϵ÷²¢¼¤»îËù½éµ¼¡£ÄâÓÃELISA,ÃâÒß×黯,western-blot,RT-PCR,ĤƬǯ,shRNA¸ÉÈźͷι¦ÄÜ·ÖÎöµÈ·½·¨ÓèÒÔÑéÖ¤,ÒÔÆÚ½ÒʾÑÏÖØÏø´Ê±ÆøµÀÃÔ×ßÉñ¾½ôÕÅÐÔÔöÇ¿µÄ»úÖÆ²¢·¢ÏÖÐÂÁÆ·¨¡£ Asthma is a chronic inflammatory airway disease with augmented tonic and reflex airway vagal activity. In its lethal attack, airway vagal tone is exaggerated and persistent even without consistent severe airway inflammation; inhalation of glucocorticoids and application of ¦Â2-adrenergic agonists are poorly effective whereas assistant anti-cholinergic agents are satisfactory in its control. The central mechanisms of exaggerated airway vagal tone in lethal asthma attack are unknown. In our preliminary study, microglia were found to be activated in the sensory relay center [the nucleus tractus solitarius (NTS)] and airway vagal efferent centers. In this proposal, we hypothesize that microglia in airway vagal centers are alternatively and predominantly polarized to their M2 type releasing brain-derived neurotrophic factor (BDNF), which, via activation of its TrkB receptors in airway vagal preganglionic neurons (AVPNs), causes up-regulation of Na+-K+-2Cl- co-transporter 1 (NKCC1) and down-regulation of K+-Cl- co-transporter 2 (KCC2) in these neurons, leading to weakened or reversed response of them to inhibitory neurotransmitters, and consequently enhances airway vagal tone. Since ATP plays an important role in the activation of microglia, we further hypothesize that the polarization of microglia in the air vagal centers of asthmatics is mediated by down-regulation of ectonucleotidases CD39 and CD73, and upregulation and activation of purinergic P2X4 receptors (P2X4R). ELISA, imunohistochemical staining, western-blot, RT-PCR, patch-clamp, shRNA interference and pulmonary function analysis are to be used to test these hypotheses. Execution of this project is significant for revealing the central mechanisms of enhanced airway vagal tone in lethal asthma attack and for discovery of new anti-asthma therapy. |
3Â¥2022-08-17 17:02:49













»Ø¸´´ËÂ¥